Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Neuroethics|November 9, 2023
When the Trial Ends: The Case for Post-Trial Provisions in Clinical Psychedelic ResearchEdward Jacobs, Ashleigh Murphy-Beiner, Ian Rouiller, et al.
Frontiers in Psychology|May 30, 2023
ARC: a framework for access, reciprocity and conduct in psychedelic therapiesMeg J Spriggs, Ashleigh Murphy-Beiner, Roberta Murphy, et al.
Plos One|October 24, 2023
Extended difficulties following the use of psychedelic drugs: A mixed methods studyJules Evans, Oliver C Robinson, Eirini Ketzitzidou Argyri, et al.
The New England Journal of Medicine|April 14, 2021
Trial of Psilocybin versus Escitalopram for DepressionRobin Carhart-Harris, Bruna Giribaldi, Rosalind Watts, et al.
Psychological Medicine|June 2, 2023
Personality change in a trial of psilocybin therapy v. escitalopram treatment for depressionBrandon Weiss, Induni Ginige, Lu Shannon, et al.
Frontiers in Pharmacology|April 18, 2022
Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for DepressionRoberta Murphy, Hannes Kettner, Rick Zeifman, et al.
Nature Medicine|February 16, 2026
A short-acting psychedelic intervention for major depressive disorder: a phase IIa randomized placebo-controlled trialDavid Erritzoe, Tommaso Barba, Tiffanie Benway, et al.
Pageof 1